Eli Lilly shares are trading lower in possible reaction to a report showing most patients using weight loss drugs like stop within a year.
Portfolio Pulse from Benzinga Newsdesk
Eli Lilly's shares are trading lower possibly due to a report indicating that most patients using weight loss drugs, similar to those produced by the company, stop within a year.
July 11, 2023 | 7:39 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Eli Lilly's stock is trading lower, potentially due to a report showing most patients stop using weight loss drugs within a year.
The report indicating high discontinuation rates for weight loss drugs could negatively impact Eli Lilly's revenues from these products, leading to a decrease in the company's stock price.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100